Search results:


The pahtway p641 has 65 genes in the original annotation. Currently, there are 46 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.

Gene ID Symbol Synonyms Official Full Name Start Site End Site Location
23411SIRT1SIR2 | SIR2L1 | SIR2alphasirtuin 110q21.3
6688SPI1OF | PU.1 | SFPI1 | SPI-1 | SPI-ASpi-1 proto-oncogene11p11.2
4654MYOD1MYF3 | MYOD | PUM | bHLHc1myogenic differentiation 111p15.4
595CCND1BCL1 | D11S287E | PRAD1 | U21B31cyclin D111q13
894CCND2KIAK0002 | MPPH3cyclin D212p13
1027CDKN1BCDKN4 | KIP1 | MEN1B | MEN4 | P27KIP1cyclin-dependent kinase inhibitor 1B12p13.1-p12
11016ATF7ATFAactivating transcription factor 712q13
1019CDK4CMM3 | PSK-J3cyclin-dependent kinase 412q14
4193MDM2ACTFS | HDMX | hdm2MDM2 proto-oncogene12q14.3-q15
5925RB1OSRC | PPP1R130 | RB | p105-Rb | pRb | pp110retinoblastoma 113q14.2
7027TFDP1DILC | DP1 | DRTF1 | Dp-1transcription factor Dp-113q34
145258GSCSAMSgoosecoid homeobox14q32.1
1387CREBBPCBP | KAT3A | RSTSCREB binding protein16p13.3
26574AATFBFR2 | CHE-1 | CHE1 | DEDapoptosis antagonizing transcription factor17q12
7343UBTFNOR-90 | UBF | UBF-1 | UBF1 | UBF2upstream binding transcription factor, RNA polymerase I17q21.31
1786DNMT1ADCADN | AIM | CXXC9 | DNMT | HSN1E | MCMT | m.HsaIDNA (cytosine-5-)-methyltransferase 119p13.2
6597SMARCA4BAF190 | BAF190A | BRG1 | MRD16 | RTPS2 | SNF2 | SNF2L4 | SNF2LB | SWI2 | hSNF2bSWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 419p13.2
898CCNE1CCNE | pCCNE1cyclin E119q12
1050CEBPAC/EBP-alpha | CEBPCCAAT/enhancer binding protein alpha19q13.1
3065HDAC1GON-10 | HD1 | RPD3 | RPD3L1histone deacetylase 11p34
1870E2F2E2F-2E2F transcription factor 21p36
2033EP300KAT3B | RSTS2 | p300E1A binding protein p30022q13.2
5600MAPK11P38B | P38BETA2 | PRKM11 | SAPK2 | SAPK2B | p38-2 | p38Betamitogen-activated protein kinase 1122q13.33
1386ATF2CRE-BP1 | CREB-2 | CREB2 | HB16 | TREB7activating transcription factor 22q32
5077PAX3CDHS | HUP2 | WS1 | WS3paired box 32q35
4286MITFCMM8 | MI | WS2 | WS2A | bHLHe32microphthalmia-associated transcription factor3p13
5468PPARGCIMT1 | GLM1 | NR1C3 | PPARG1 | PPARG2 | PPARgammaperoxisome proliferator activated receptor gamma3p25
5894RAF1CMD1NN | CRAF | NS5 | Raf-1 | c-RafRaf-1 proto-oncogene, serine/threonine kinase3p25
1487CTBP1BARSC-terminal binding protein 14p16
6502SKP2FBL1 | FBXL1 | FLB1 | p45S-phase kinase-associated protein 2, E3 ubiquitin protein ligase5p13
4208MEF2CC5DELq14.3 | DEL5q14.3myocyte enhancer factor 2C5q14.3
8841HDAC3HD3 | RPD3 | RPD3-2histone deacetylase 35q31
5515PPP2CAPP2Ac | PP2CA | PP2Calpha | RP-Cprotein phosphatase 2 catalytic subunit alpha5q31.1
1437CSF2GMCSFcolony stimulating factor 25q31.1
860RUNX2AML3 | CBF-alpha-1 | CBFA1 | CCD | CCD1 | CLCD | OSF-2 | OSF2 | PEA2aA | PEBP2aArunt related transcription factor 26p21
896CCND3-cyclin D36p21
1026CDKN1ACAP20 | CDKN1 | CIP1 | MDA-6 | P21 | SDI1 | WAF1 | p21CIP1cyclin-dependent kinase inhibitor 1A6p21.2
6046BRD2D6S113E | FSH | FSRG1 | NAT | O27.1.1 | RING3 | RNF3bromodomain containing 26p21.3
1432MAPK14CSBP | CSBP1 | CSBP2 | CSPB1 | EXIP | Mxi2 | PRKM14 | PRKM15 | RK | SAPK2A | p38 | p38ALPHAmitogen-activated protein kinase 146p21.3-p21.2
1871E2F3E2F-3E2F transcription factor 36p22
6908TBPGTF2D | GTF2D1 | HDL4 | SCA17 | TFIIDTATA-box binding protein6q27
1021CDK6MCPH12 | PLSTIREcyclin-dependent kinase 67q21-q22
1052CEBPDC/EBP-delta | CELF | CRP3 | NF-IL6-betaCCAAT/enhancer binding protein delta8p11.2-p11.1
1029CDKN2AARF | CDK4I | CDKN2 | CMM2 | INK4 | INK4A | MLM | MTS-1 | MTS1 | P14 | P14ARF | P16 | P16-INK4A | P16INK4 | P16INK4A | P19 | P19ARF | TP16cyclin-dependent kinase inhibitor 2A9p21
25ABL1ABL | JTK7 | bcr/abl | c-ABL | c-ABL1 | p150 | v-ablABL proto-oncogene 1, non-receptor tyrosine kinase9q34.1
6872TAF1BA2R | CCG1 | CCGS | DYT3 | DYT3/TAF1 | KAT4 | MRXS33 | N-TAF1 | NSCL2 | OF | P250 | TAF(II)250 | TAF2A | TAFII-250 | TAFII250 | XDPTATA-box binding protein associated factor 1Xq13.1


Copyright © Bioinformatics and Systems Medicine Laboratory All Rights Reserved since 2009.